TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA May 23, 1986
TCL Archive In Brief: William Longmire Replaces Fisher On Cancer Panel; Talbot Urges Organizations To Avoid Polarization July 9, 1982
TCL Archive In Brief: Maryland Wins Center Planning Grant; CRC Receives $5 Million To Endow Chair December 10, 1999
TCL Archive NCI To Appoint Expert Group To Consider Standards For Outcomes Measurement. September 29, 2000
